Producer: Bullet Finance.
On January 29, it was reported that the stock price of Hasen Trading (China) shares fell after the opening today, and the current stock price is 129 yuan shares, a one-day decline of 998%, corresponding to a total market capitalization of 285.2 billion yuan.
This is the third consecutive trading day that the company's shares have fallen to the limit, and the company's shares have appeared 1001% and 999%**.
The share price of Hasen shares has recently seen a rollercoaster performance, from January 16 to January 24, the company has 7 consecutive trading days of stock price limit, the stock price from January 16 to 9$98 shares** to January 24** of 17$69 shares. However, since then, their stock price has fallen for three consecutive trading days.
On January 18th, January 20th, January 24th and January 27th, Hasen shares also issued many announcements on abnormal trading fluctuations.
Hasen Co., Ltd. said that on January 16, 2024, the company disclosed the "Hasen Trading (China) Co., Ltd. *** Issuance of Shares and Payment of Cash to Purchase Assets and Raise Matching Funds and Related Party Transaction Plan" and other announcements and documents. The audit and evaluation of the assets involved in this transaction have not yet been completed; The transaction is subject to the necessary internal decision-making procedures and the approval of the competent regulatory authorities before it can be formally implemented, and there is uncertainty as to whether it can be implemented, so they draw investors' attention to the above risks. At present, the company's main business is still the brand operation, product design and sales of mid-to-high-end leather shoes.
Hasen shares own Hasen, Cardina, Hasen men's shoes, Nobeda, wheat shoes and other brands, known as the "king of leather shoes".
Hasen shares want to acquire 90% of the equity of Jiangsu Lucent Industrial Intelligent Equipment, 45% of the equity of Suzhou Langx Precision Hardware, and Suzhou Yeyu Enterprise Management Partnership (Limited Partnership) 230769% of the share, and raise matching funds.
They also admitted in the announcement that after the completion of this transaction, they will increase the research and development, production and sales of precision metal structural parts and automation equipment series products in the existing business segment. The company will face operational and management challenges, including organizational structure, internal control and talent introduction. After the completion of this transaction, there is uncertainty about whether the company can integrate the underlying assets and give full play to its competitive advantages, and there is a risk of acquisition and integration in this transaction.
On January 24, Hasen shares also received an inquiry letter from the Shanghai ** Exchange about the transaction, and Hasen shares need to add information on the business and financial situation of the underlying assets, as well as the company's integration arrangements after the transaction, and whether the target company has the risk of being punished by the competent authorities.
According to the 2023 performance forecast released by Hasen on January 25 this year, the company expects to achieve a net profit attributable to shareholders of listed companies of -2.5 million yuan to -5 million yuan in 2023. In the same period, the company's non-recurring profit and loss affected the amount of about 17.66 million yuan, and the company expects to achieve a net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses in 2023 -20.16 million yuan to -22.66 million yuan.
In the future, whether the share price of Hasen shares will continue to be **, we will continue to pay attention.
Card game sprint IPO, the business model is CCTV** needs to be supervised, and Li Qibin has been invested by Tencent.
Tongyuankang Pharmaceutical sprinted to the IPO of the Hong Kong Stock Exchange, with a loss of 5 in 21 months800 million, 0 revenue in the first three quarters of 2023.
Shenghua New Materials expects net profit to decline by more than 97% in 2023, and the rationality of fundraising and investment expansion has been questioned.